<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00805597</url>
  </required_header>
  <id_info>
    <org_study_id>LC2008B06</org_study_id>
    <nct_id>NCT00805597</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes</brief_title>
  <official_title>A Phase â…¢ Randomized Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate postmastectomy radiotherapy in breast cancer
      patients with one to three positive nodes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible breast cancer patients with mastectomy and axillary dissection are randomized into 2
      groups:radiotherapy of 50 Gy in 25 fractions within 5 weeks to ipsilateral chest wall and
      supraclavicular nodal region,and no radiotherapy.

      During and after radiotherapy, the patients are followed and the efficacy and toxicities of
      radiotherapy are evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The recuiting was to slow to complete the study
  </why_stopped>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>loco-regional recurrence</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>radiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>radiotherapy of 50Gy/25/f/5w to the ipsilateral chest wall and supraclavicular region</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no radiotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>no radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation</intervention_name>
    <description>radiotherapy of 50Gy/25f/5w to the chest wall and supraclavicular nodal region</description>
    <arm_group_label>radiotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>no radiation</intervention_name>
    <description>no radiotherapy</description>
    <arm_group_label>no radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ipsilateral histologically confirmed invasive breast cancer

          -  Undergone total mastectomy and axillary dissection

          -  T1-2 and one to three axillary lymph nodes positive

          -  A minimum of 10 axillary nodes dissected

          -  Fit for chemotherapy(if indicated),endocrine therapy(if indicated)and postoperative
             irradiation

          -  Written,informed consent

        Exclusion Criteria:

          -  Patients who undergone previous irradiation to the ipsilateral chest wall and
             supraclavicular region

          -  Previous or concurrent malignant other than non-melanomatous skin cancer

          -  Unable or unwilling to give informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ye-xiong Li, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Cancer Institute and Hospital, Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cancer Hospital, Chinese Academy of Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <zip>100021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2008</study_first_submitted>
  <study_first_submitted_qc>December 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2008</study_first_posted>
  <last_update_submitted>August 4, 2016</last_update_submitted>
  <last_update_submitted_qc>August 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Shu lian Wang</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>mastectomy</keyword>
  <keyword>one to three positive nodes</keyword>
  <keyword>radiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

